SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-11-013304
Filing Date
2011-02-14
Accepted
2011-02-14 11:26:48
Documents
1
Group Members
CON EGANCONOR O'DRISCOLLFULVIO DOBRICHMELDRUM ASSET MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A b84912sc13gza.htm SC 13G/A 79564
  Complete submission text file 0000950123-11-013304.txt   81912
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 11603382
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITI HEDGE FUND SERVICES 1748GT 24 HOSPITAL ROAD GRAND CAYMAN E9 000000
Business Address C/O CITI HEDGE FUND SERVICES 1748GT 24 HOSPITAL ROAD GRAND CAYMAN E9 000000 212-317-4815
Rockall Emerging Markets Master Fund Ltd (Filed by) CIK: 0001436169 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A